Bharat Rasayan profit and loss

Latest FY26

Revenue: ₹1,242cr+5.9% on FY25
EBITDA: ₹199cr+13.9% on FY25
Net profit: ₹146cr+3.4% on FY25
EPS: ₹87.67−74.1% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,203	1,242	1,173	1,045	1,234	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	39.7	41.2	26.0	20.9	19.3
	1,242	1,283	1,199	1,066	1,254
	819	799	825	678	855
	−37.7	6.6	−47.6	43.0	−15.5
	93.2	90.5	85.4	84.5	87.1
	4.4	4.6	4.7	3.0	5.8
	27.0	26.4	27.0	25.8	26.0
	151	146	136	122	111
	1,057	1,074	1,030	956	1,069
	177	199	175	117	197
	150	173	148	91.5	171
Profit
	185	209	169	109	185
	−4.0	−18.8	0.0	0.0	−4.6
	181	191	169	109	180
	44.8	43.5	39.7	25.3	49.8
	0.3	4.2	4.4	2.5	−0.4
	45.1	47.7	44.1	27.8	49.4
	4.0	2.8	15.8	13.9	−6.2
	140	146	141	95.5	125
	136	143	125	81.6	131
	−0.5	−0.4	0.1	−0.2	−0.7
	139	145	141	95.3	124
	—	146	141	95.5	125
Per share
	₹136.53	₹87.67	₹339.14	₹229.86	₹299.89
	₹136.53	₹87.67	₹339.14	₹229.86	₹299.89
Other comprehensive income — detail
	−0.5	−0.4	0.1	—	—
	0.5	0.4	−0.1	—	—
	—	—	—	0.2	0.7
	—	146	141	95.5	125
Per share — as-filed variants
	₹136.53	₹87.67	₹339.14	₹229.86	₹299.89
	₹136.53	₹87.67	₹339.14	₹229.86	₹299.89
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	421	436	396	324	395
	35.0%	35.1%	33.8%	31.0%	32.0%
Adjusted (ex-exceptional items) — derived
	185	209	169	109	185
	−4.0	−18.8	0.0	0.0	−4.6
	143	160	141	95.5	128
	₹139.49	₹96.16	₹339.14	₹229.86	₹307.89

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BHARATRAS₹943.70

Bharat Rasayan Limited

· Chemicals

Annual Quarterly₹ CrorePeersINSECTICID IPL MOL GSPCROP PUNJABCHEM ASTEC BHAGCHEM NACLINDMcap ₹1,569 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,234.3	1,044.6	1,173.0	1,241.8	1,202.6
Other Income	19.3	20.9	26.0	41.2	39.7
Total Income	1,253.7	1,065.5	1,199.0	1,283.1	1,242.3
Expenses
+ Cost of Materials Consumed	854.5	678.1	824.5	799.2	819.4
+ Changes in Inventories	-15.5	43.0	-47.6	6.6	-37.7
+ Employee Benefit Expense	87.1	84.5	85.4	90.5	93.2
+ Finance Costs	5.8	3.0	4.7	4.6	4.4
+ Depreciation & Amortisation	26.0	25.8	27.0	26.4	27.0
+ Other Expenses	110.9	121.8	135.8	146.4	151.0
Total Expenses	1,068.9	956.1	1,029.8	1,073.7	1,057.3
EBITDA	197.3	117.3	174.9	199.1	176.7
EBIT	171.3	91.5	147.9	172.8	149.7
Profit
PBT before Exceptional Items	184.8	109.4	169.2	209.4	185.0
+ Exceptional Items	-4.6	0.0	0.0	-18.8	-4.0
Pretax Income	180.2	109.4	169.2	190.6	181.0
+ Current Tax	49.8	25.3	39.7	43.5	44.8
+ Deferred Tax	-0.4	2.5	4.4	4.2	0.3
Tax Expense	49.4	27.8	44.1	47.7	45.1
+ Share of Associates & JVs	-6.2	13.9	15.8	2.8	4.0
Net Income	124.6	95.5	140.9	145.7	139.9
+ Net Income — Continuing Ops	130.8	81.6	125.1	142.9	135.9
+ Other Comprehensive Income	-0.7	-0.2	0.1	-0.4	-0.5
Total Comprehensive Income	123.9	95.3	141.0	145.3	139.3
Net Income to Common	124.6	95.5	140.9	145.7	—
Per Share
Basic EPS	299.89	229.86	339.14	87.67	136.53
Diluted EPS	299.89	229.86	339.14	87.67	136.53
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.1	-0.4	-0.5
+ Tax on Items NOT to be Reclassified	—	—	-0.1	0.4	0.5
+ Tax on Items NOT to be Reclassified — alt tag	0.7	0.2	—	—	—
Comprehensive Income — Owners of Parent	124.6	95.5	140.9	145.7	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	299.89	229.86	339.14	87.67	136.53
Diluted EPS — Continuing Operations	299.89	229.86	339.14	87.67	136.53
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	395.3	323.6	396.0	436.1	420.9
Gross Margin %	32.02	30.98	33.76	35.11	35.00
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	184.8	109.4	169.2	209.4	185.0
− Exceptional Items (reconciliation)	-4.6	0.0	0.0	-18.8	-4.0
Net Income Adj (tax-effected)	127.9	95.5	140.9	159.8	142.9
EPS Adj	307.89	229.86	339.14	96.16	139.49
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	5.00	5.00
Paid Up Equity Capital	4.2	4.2	4.2	8.3	8.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.